Screener
Mirum Pharmaceuticals, Inc. MIRM EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s EPS (diluted)?
- Mirum Pharmaceuticals, Inc. (MIRM) reported EPS (diluted) of -$1.06 in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s EPS (diluted) changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s EPS (diluted) decreased by 783.3% year-over-year, from -$0.12 to -$1.06.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s EPS (diluted)?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s EPS (diluted) has grown at a -50.4% compound annual growth rate (CAGR), from -$4.02 to -$0.49.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Mirum Pharmaceuticals, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude